Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

VANJANI, RAHUL

NPI: 1134487135 · PROVIDENCE, RI 02907 · Internal Medicine Physician · NPI assigned 04/26/2012

$119K
Total Medicaid Paid
2,520
Total Claims
2,086
Beneficiary Records
11
Codes Billed
2018-03
First Month
2022-10
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 312 $17K
2019 487 $21K
2020 648 $39K
2021 737 $28K
2022 336 $14K

Billing Codes

CodeDescriptionClaimsBene. RecordsTotal Paid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,344 1,064 $59K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 83 62 $11K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 210 198 $11K
36415 Collection of venous blood by venipuncture 393 318 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 85 85 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 63 49 $7K
83036 Hemoglobin; glycosylated (A1C) 206 189 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 47 39 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 25 25 $2K
80061 Lipid panel 37 33 $1K
80053 Comprehensive metabolic panel 27 24 $1K